Jane Street Group, LLC Cara Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$9.94 - $12.65 $292,236 - $371,910	-29,400 Reduced 63.36%	17,000 $207,000
Q4 2021 Feb 15, 2022	SELL	$11.99 - $18.14 $400,466 - $605,876	-33,400 Reduced 41.85%	46,400 $565,000
Q3 2021 Nov 16, 2021	BUY	$11.55 - $16.06 $595,980 - $828,695	51,600 Added 182.98%	79,800 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $531,102 - $1.25 Million	-42,900 Reduced 60.34%	28,200 $402,000
Q1 2021 May 18, 2021	BUY	$15.07 - $21.71 $828,850 - $1.19 Million	55,000 Added 341.61%	71,100 $1.54 Million

Q4 2020 Feb 17, 2021	SELL	$12.72 - $16.16 $2,544 - $3,232	-200 Reduced 1.23%	16,100 $244,000
Q2 2020 Aug 17, 2020	BUY	$12.39 - $17.33 $201,957 - $282,479	16,300 New	16,300 $279,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.